Pharmacophore discovery - Lessons learned

Current Pharmaceutical Design

Volumn 9, Issue 20, 2003, Pages 1649-1664

  van Drie, John H ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; ANTIBIOTIC AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE DERIVATIVE; LINEZOLID; OXAZOLIDINONE DERIVATIVE;

CONTROLLED STUDY; DATA BASE; DRUG CONFORMATION; DRUG DESIGN; DRUG DETERMINATION; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; EXPERIENCE; MATHEMATICAL COMPUTING; METHODOLOGY; MOLECULAR MODEL; MONTE CARLO METHOD; PHARMACOPHORE; PRIORITY JOURNAL; PROBLEM SOLVING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR AFFINITY; REVIEW; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; X RAY ANALYSIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; MODELS, MOLECULAR; MOLECULAR CONFORMATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0041488802     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033454568     Document Type: Review

References (43)

1. Marshall GR, Barry CD, Bosshard HE, Dammkoehler RA, Dunn DA. The Conformational Parameter in Drug Design: The Active Analog Approach. In: Computer-Assisted Drug Design, Olson EC, Christofersen RE. Eds. Washington: Amer Chem Soc 1979; pp 205-226.
2. Van Drie JH,Weininger D Martin YC. ALADDIN: An Integrated Tool for Computer-Assisted Molecular Design and Pharmacophoric Pattern Recognition from Geometric, Steric and Substructure Searching of Three-Dimensional Molecular Structures. J Comp Aided Mol Des 1989; 3: 225-251.
3. Van Drie JH. 3D Database Searching in Drug Discovery. Netsci 1995; www.netsci.org/Science/Cheminform/feature06.html.
4. Van Drie JH. An inequality for 3D database searching and its use in evaluating the treatment of conformational flexibility. J Comp Aided Mol Des 1996; 10: 623-631.
5. Van Drie JH. Strategies for the determination of pharmacophoric 3D database queries. J Comp Aided Mol Des 1997; 11: 39-52.
6. Van Drie JH. "Shrink-Wrap" Surfaces: A New Method for Incorporating Shape into Pharmacophoric 3D Database Searching. J Chem Info Comp Sci 1997; 37: 38-42.
7. Van Drie JH, Nugent RA. Addressing the challenges of combinatorial chemistry: 3D databases, pharmacophore recognition and beyond. SAR and QSAR in Env Res 1998; 9: 1-21.
8. H-D. Höltje H-D. Pharmacophore identification and receptor mapping. In The Practice of Medicinal Chemistry, Wermuth CG, Ed, London: Academic Press 1996; pp. 437-458.
9. Bures M. Recent Techniques and Applications in Pharmacophore Mapping. In Practical Applications of Computer-Aided Drug Design, Charifson P, Ed, New York: Dekker 1997; pp 39-72.
10. Van Drie JH. Pharmacophore discovery - a critical review. In Computational Medicinal Chemistry and Drug Discovery, Tollenaere JP, Bultinck P, de Winter H. and Langenaeker W, Eds, New York: Dekker, in press.
11. Martin YC. 3D database searching in drug design. J Med Chem 1992; 35: 2145-54.
12. Shoichet BK, Stroud RM, Santi DV, Kuntz ID, Perry KM. Structure-based discovery of inhibitors of thymidylate synthase. Science 1993; 259: 1445-50.
13. Kubinyi H. 3D-QSAR in Drug Design Volume 1: Theory Methods and Applications, Amsterdam: Kluwer Academic Publishers 1993.
14. Cramer RD, Patterson DE, Bunce JD. Comparative Molecular Field Analysis (CoMFA). Effect of Shape on Binding of Steroids to Carrier Proteins. J Amer Chem Soc 1988; 1110: 5959-67.
15. Hilpert K, Ackermann J, Banner DW, Gast A, Gubernator K, Hadvary P, et al. Design and synthesis of potent and highly selective thrombin inhibitors. J Med Chem 1994; 37: 3889-901.
16. Smellie A, Teig SL, Towbin P. Poling: Promoting conformational variation. J Comp Chem 1995; 16, 171 -87.
17. Chang G, Guida W, Still W. An internal coordinate monte-carlo method for searching conformational space. J Amer Chem Soc 1989; 111: 4379-86. See also Macromodel 8.0 reference manual, available from Schrodinger, Inc. http://www.schrodinger.com/docs/mm8.0/pdf/ MMntafn̄ual/MM-Minta.pdf
18. Halgren TA. Merck Molecular Force Field. I. Basis, Form Scope, Parameterization and Performance of MMFF94. J. Comput Chem 1996; 17: 490-519, et seq.
19. Gundertofte K, Li1jefors T, Norrby PO, Pettersson I. A Comparison of Conformational Energies Calculated by Several Molecular Mechanics Methods. J Comput Chem 1996; 17: 429-49.
20. Omega is software based on unpublished methodology, available from Open Eye Scientific Software, www.eyesopen.com.
21. ONFORT is software based on unpublished methodology, available from R. S. Pearlman, Univ. of Texas, Austin, TX
22. Cavalli A, Poluzzi E, De Ponti F, Recanatini M. Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. J Med Chem 2002; 45: 3844-53. While some aspects of their computational protocol may be disputed, these authors are to be commended for the level of detail they provide about their protocol.
23. Jain AN, Koile K, Chapman D. Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark. J Med Chem 1994; 37: 2315-27.
24. Mayer D, Naylor CB, Motoc I, Marshall GR. A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies. J Comp Aided Mol Des 1987; 1: 3-16.
25. This database is available from the National Cancer Institute, and represents a collection of drug-like molecules submitted to the NCI for carcinogenicity evaluation. http://cactus.nci.nih.gov/ncidb2/download.html
26. For example TenBrink RE. Oxazinocarbazoles for the treatment of CNS diseases. US Patent 6,448,397, Sept. 10, 2002
27. Nilsson, B. et al. Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases. US Patent 6,465,467, Oct. 15, 2002.
28. Kabsch W. A Solution for the Best Rotation to Relate Two Sets of Vectors. Acta Cryst. 1976; A32, 922-3;
29. Kabsch, W. A discussion of the solution for the best rotation to relate two sets of vectors. Acta Cryst 1978; A34, 827.
30. Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, et al. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives. J Med Chem 1997; 40: 2997-08;
31. Bromidge SM, Dabbs S, Davies DT, Duckworth DM, Forbes IT, Ham P, et al. Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines. J Med Chem 1998; 41: 1598-1612.
32. Brickner SJ, Hutchinson DK, Barbachyn MR, Manninen PR, Ulanowicz DA, Garmon SA, et al. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J Med Chem 1996; 39: 673-9.
33. The allusion is by V. E. Groppi to the "gonzo journalism" of Thompson HS, e.g. Fear & Loathing in Las Vegas, New York: Random House, 1973.
34. McGovern SL, Caselli E, Grigorieff N, Shoichet BK. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002; 45: 1712-22.
35. Kubinyi H, Hamprecht FA, Mietzner T. Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices. J Med Chem 1998; 41: 2553-64.
36. Golbraikh T. anq Tropsha A. Beware of q2! J Mol Graph Model 2002; 20: 269-76.
37. Mason JS, Good AC, Martin EJ. 3-D pharmacophores in drug discovery. Curr Pharm Des 2001; 7: 567-97.
38. Bradley EK, Beroza P, Penzotti JE, Grootenhuis PD, Spellmeyer DC, Miller JL. A rapid computational method for lead evolution: description and application to alpha(I)-adrenergic antagonists. J Med Chem 2000; 43: 2770-4.
39. Mestres J, Rohrer DC, Maggiora GM. A molecular field-based similarity approach to pharmacophoric pattern recognition. J Mol Graph Model 1997; 15: 114: 15, 103
40. Jones G, Willett P, Glen RC. A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. J Comp Aided Mol Des 1995; 9: 532-49.
41. Langer T, Hoffmann RD. Virtual screening: an effective tool for lead structure discovery? Curr Pharm Des 2001; 7(7): 509-27.
42. Li Y, Harte WE. A review of molecular modeling approaches to pharmacophore models and structure-activity relationships of ion channel modulators in CNS. Curr Pharm Des 2002; 8(2): 99-110.
43. Wong MG, Tehan BG, Lloyd EJ. Molecular mapping in the CNS. Curr Pharm Des 2002; 8(17): 1547-70.